In ET, patients with CALR mutations showed male predominance, higher platelet counts, lower hemoglobin levels and leukocyte counts, and a lower risk of thrombosis than patients with JAK2 and MPL mutations [4]. Here, JAK2 is linked to deep vein thrombosis.